azathioprine has been researched along with Cancer of Prostate in 7 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
"Side effects of long-term use of azathioprine in myasthenia gravis are infrequently reported." | 7.71 | Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine. ( Barthelmes, L; Seale, JR; Thomas, KJ, 2002) |
" Events included eight patients with malignancies, two with pancytopenia taking methotrexate, three with septic arthritis, and two with septicaemias." | 3.71 | Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience. ( Bevan, J; Homer, D; Jobanputra, P; Maggs, F, 2002) |
"Side effects of long-term use of azathioprine in myasthenia gravis are infrequently reported." | 3.71 | Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine. ( Barthelmes, L; Seale, JR; Thomas, KJ, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jobanputra, P | 1 |
Maggs, F | 1 |
Homer, D | 1 |
Bevan, J | 1 |
Barthelmes, L | 1 |
Thomas, KJ | 1 |
Seale, JR | 1 |
Kleinclauss, F | 1 |
Gigante, M | 1 |
Neuzillet, Y | 1 |
Mouzin, M | 1 |
Terrier, N | 1 |
Salomon, L | 1 |
Iborra, F | 1 |
Petit, J | 1 |
Cormier, L | 1 |
Lechevallier, E | 1 |
Batiuk, TD | 1 |
Barry, JM | 1 |
Bennett, WM | 1 |
Meyer, MM | 1 |
Tolzman, D | 1 |
Norman, DJ | 1 |
Elliott, GB | 1 |
Silverberg, DS | 1 |
Dossetor, JB | 1 |
Muir, CS | 1 |
Jacobs, SC | 1 |
McLaughlin, AP | 1 |
Gittes, RF | 1 |
Prejean, JD | 1 |
Griswold, DP | 1 |
Weisburger, JH | 1 |
1 trial available for azathioprine and Cancer of Prostate
Article | Year |
---|---|
Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.
Topics: Adenoma, Bile Duct; Age Factors; Azathioprine; Cyclosporine; Follow-Up Studies; Humans; Immunosuppre | 1993 |
6 other studies available for azathioprine and Cancer of Prostate
Article | Year |
---|---|
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience.
Topics: Antirheumatic Agents; Arthritis, Infectious; Azathioprine; Drug Monitoring; Humans; Hypokalemia; Lun | 2002 |
Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine.
Topics: Azathioprine; Fatal Outcome; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle | 2002 |
Prostate cancer in renal transplant recipients.
Topics: Aged; Azathioprine; Calcineurin Inhibitors; France; Humans; Immunosuppressive Agents; Kidney Transpl | 2008 |
Latent carcinoma of the prostate in a 24-year-old man receiving cyclophosphamide and azathioprine.
Topics: Adenocarcinoma; Adult; Azathioprine; Cyclophosphamide; Glomerulonephritis; Humans; Male; Prednisone; | 1977 |
Effects of immunosuppression on the rejection of methylcholanthrene tumor isografts.
Topics: Animals; Antigens, Neoplasm; Azathioprine; Carcinoma, Squamous Cell; Graft Rejection; Immunosuppress | 1977 |
Transplantation of allogeneic tumors in rats and mice treated with azathioprine, prednisone and antilymphocyte serum.
Topics: Adenocarcinoma; Animals; Antilymphocyte Serum; Azathioprine; Carcinoma, Hepatocellular; Immunosuppre | 1972 |